NDC Compounded Drug 71300-6555-1 Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride
Injection, Solution Intra-articular; Soft Tissue; Subcutaneous
Compounded Drug Product Information
Frequently Asked Questions
What is the NDC number assigned to Dexamethasone Sodium Phosphate And Lidocaine Hcl?
Dexamethasone Sodium Phosphate And Lidocaine Hcl was assigned by its manufacturer with NDC product code 71300-6555. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Dexamethasone Sodium Phosphate And Lidocaine Hcl?
The NDC package code 71300-6555-1 was assigned to a 1.5 mL in 1 BOX of dexamethasone sodium phosphate; lidocaine hydrochloride administered intra-articular; soft tissue; subcutaneous via injection, solution.
Who manufactures this product?
Dexamethasone Sodium Phosphate And Lidocaine Hcl is manufactured by an outsourced facility and labeled by Nubratori, Inc. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.